iPSC Culture and Application in Cell and Gene Therapy

COURSE OVERVIEW

Gain fundamental knowledge in reprogramming somatic cells into induced pluripotent stem cells (iPSCs). Through a combination of self-paced modules and interactive live-virtual discussions, you'll learn from leading global experts how to evaluate the quality and key characteristics of iPSCs, ensuring their suitability for advanced research and therapeutic applications.

COURSE CONTENT

Module 1: Reprogramming Somatic Cells to iPSCs

  • Steps involved in reprogramming somatic cells into induced pluripotent stem cells (iPSCs).
  • Workflow considerations based on the starting material used.
  • Key differences between viral and non-viral reprogramming methods.
  • Morphological features of iPSC colonies ready for selection and differentiation.
  • Characteristics of undifferentiated versus differentiated iPSC colonies.
  • Assays to evaluate iPSC quality.

Module 2: Quality by Design (QbD) in Culturing iPSCs for Cell Therapy

  • Functional characteristics of iPSCs as starting material for cell therapies.
  • Factors influencing pluripotency and quality of iPSCs.
  • Comparison between traditional and QbD-based automated cell manufacturing processes.
  • Key in-process parameters for monitoring iPSC quality during manufacturing.

Module 3: Development of Multi-Engineered, iPSC-Derived Therapeutic Products

  • Advantages of allogeneic cell therapy manufacturing.
  • Benefits of using iPSCs over immune cell types in cell therapies.
  • Differences in manufacturing workflows: iPSCs vs. immune cell types.
  • Key challenges, risk assessments, and regulatory considerations in using iPSCs for therapeutic applications.
  • The use of iPSC differentiation processes for therapy development.
LEARNING OUTCOMES
  • Describe the biology, key features, and potential applications of human pluripotent stem cells (hPSCs).
  • Understand and outline the workflow for selecting and expanding iPSC.
  • Identify and describe the critical quality attributes (CQAs) of hPSCs and their significance.
  • Demonstrate knowledge of the processes involved in hPSC manufacturing.
  • Recognize the use of iPSCs.
Live-virtual, self-paced course
Coming Soon in Spring 2025
DESIGNED FOR:
  • Professionals seeking to enhance their expertise in iPSC technology, including its applications and advancements.
  • CGT professionals and clinical researchers working in regenerative medicine or developing therapies and products based on iPSCs.
 
UPON COMPLETION, YOU WILL RECEIVE:
  • A certificate of course completion from ISCT
CONTACT US

Contact us for more information and course registration.

 PLANNING COMMITTEE 

YOU MAY ALSO BE INTERESTED IN:

The Use of Cell Therapies for Autoimmune Diseases: CAR-T

Format: In-person interactive course
Length: 1.5-day training

Led by pioneers in CAR-T cell development and applications, this in-person course covers the current state and future of CAR-T cell therapies for autoimmune diseases, addressing challenges and exploring potential solutions, along with regulatory requirements and manufacturing processes.